SEER
Seer, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.95
+0.52%Margins
Gross margin
46.3%
EBITDA margin
-463.8%
EBIT margin
-511.4%
Net margin
-490.7%
FCF margin
-319.4%
-30.1%
Return on equity
-26.5%
Return on assets
-28.6%
Return on invested capital
0.05x
Asset turnover
-$43.4M
Cash from operations
$2.76
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026